Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The Use of Sodium Hyaluronate in Freezing Media for Bovine and Murine Embryos

Identifieur interne : 001040 ( Istex/Curation ); précédent : 001039; suivant : 001041

The Use of Sodium Hyaluronate in Freezing Media for Bovine and Murine Embryos

Auteurs : A. Palasz [Canada] ; S. Alkemade [Canada] ; R. J. Mapletoft [Canada]

Source :

RBID : ISTEX:D019CD5051D47BB95787A7AA7ABAB883CD3C6665

Abstract

Abstract: Four experiments were designed to determine whether sodium hyaluronate (SH) may be used to replace newborn calf serum (NCS) in murine and bovine embryo freezing media. A total of 780 mouse and 178 cattle embryos were frozen. Freezing media were prepared in Dulbecco's phosphate-buffered saline supplemented with 20% NCS and 10% glycerol (v/v) (medium A). In experintents I and II, NCS was replaced by 0.1% SH (w/v) in medium B and by 0.1% polyvinyl alcohol (PVA) (w/v) in medium C. In experiments III and IV, NCS was replaced in mouse embryo freezing medium by three different molecular weights of SH as follows: 0.1 or 0.2% (SH-1; <3 × 105 Da) in medium B. by 0.1 or 0.05% (SH-2; 5-7.5 × 105 Da) in medium C, and by 0.1 or 0.025% (SH-3; >1.2 × 106 Da) in medium D. Embryos were frozen and thawed using standard procedures. Glycerol was diluted from embryos after thawing in a single step with 1.0 M sucrose. After 48 h in culture (Ham's F-10 medium for cattle embryos and BWW medium for mouse embryos), embryos were evaluated for development to expanded or hatched blastocysts. Survival rates were compared by X2 analysis. In experiment I, there were no significant differences in mouse embryo survival or development between NCS, SH, and PVA groups (84.1, 79.2, and 83.3%, respectively). In experiment II, there were no significant differences in bovine embryo survival between NCS and SH groups (67.2 and 67.7%), but both had significantly higher survival than the PVA group (37.9%: P < 0.05). In experiment III, there was a significantly lower (P < 0.05) embryo survival rate in the low-molecular-weight SH-1 group (18.6%) than in medium (SH-2)- or high (SH-3)-molecular-weight groups (78.6 and 92.5%, respectively). Although doubling the concentration of SH-1 in experiment IV resulted in improved embryo survival (63.4%), survival rates were significantly higher (P < 0.05) in the medium-molecular-weight (SH-2; 82.3%) and high-molecular-weight (SH-3; 86.0%) groups despite reduced concentrations of these compounds in the freezing medium. Results suggest that SH can be used to replace biological sera in embryo freezing media.

Url:
DOI: 10.1006/cryo.1993.1016

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:D019CD5051D47BB95787A7AA7ABAB883CD3C6665

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The Use of Sodium Hyaluronate in Freezing Media for Bovine and Murine Embryos</title>
<author>
<name sortKey="Palasz, A" sort="Palasz, A" uniqKey="Palasz A" first="A." last="Palasz">A. Palasz</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario, Canada N6E 2V6</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alkemade, S" sort="Alkemade, S" uniqKey="Alkemade S" first="S." last="Alkemade">S. Alkemade</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario, Canada N6E 2V6</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mapletoft, R J" sort="Mapletoft, R J" uniqKey="Mapletoft R" first="R. J." last="Mapletoft">R. J. Mapletoft</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario, Canada N6E 2V6</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D019CD5051D47BB95787A7AA7ABAB883CD3C6665</idno>
<date when="1993" year="1993">1993</date>
<idno type="doi">10.1006/cryo.1993.1016</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-3S4T7G12-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001040</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001040</idno>
<idno type="wicri:Area/Istex/Curation">001040</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">The Use of Sodium Hyaluronate in Freezing Media for Bovine and Murine Embryos</title>
<author>
<name sortKey="Palasz, A" sort="Palasz, A" uniqKey="Palasz A" first="A." last="Palasz">A. Palasz</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario, Canada N6E 2V6</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alkemade, S" sort="Alkemade, S" uniqKey="Alkemade S" first="S." last="Alkemade">S. Alkemade</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario, Canada N6E 2V6</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mapletoft, R J" sort="Mapletoft, R J" uniqKey="Mapletoft R" first="R. J." last="Mapletoft">R. J. Mapletoft</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario, Canada N6E 2V6</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Herd Medicine and Theriogenology, Western College of Veterinary Medicine, University of Saskalchewan, Saskatoon, Saskatchewan, Canada S7N 0W0; and Vetrepharm Inc., London, Ontario</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Cryobiology</title>
<title level="j" type="abbrev">YCRYO</title>
<idno type="ISSN">0011-2240</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1993">1993</date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="172">172</biblScope>
<biblScope unit="page" to="178">178</biblScope>
</imprint>
<idno type="ISSN">0011-2240</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0011-2240</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Four experiments were designed to determine whether sodium hyaluronate (SH) may be used to replace newborn calf serum (NCS) in murine and bovine embryo freezing media. A total of 780 mouse and 178 cattle embryos were frozen. Freezing media were prepared in Dulbecco's phosphate-buffered saline supplemented with 20% NCS and 10% glycerol (v/v) (medium A). In experintents I and II, NCS was replaced by 0.1% SH (w/v) in medium B and by 0.1% polyvinyl alcohol (PVA) (w/v) in medium C. In experiments III and IV, NCS was replaced in mouse embryo freezing medium by three different molecular weights of SH as follows: 0.1 or 0.2% (SH-1; <3 × 105 Da) in medium B. by 0.1 or 0.05% (SH-2; 5-7.5 × 105 Da) in medium C, and by 0.1 or 0.025% (SH-3; >1.2 × 106 Da) in medium D. Embryos were frozen and thawed using standard procedures. Glycerol was diluted from embryos after thawing in a single step with 1.0 M sucrose. After 48 h in culture (Ham's F-10 medium for cattle embryos and BWW medium for mouse embryos), embryos were evaluated for development to expanded or hatched blastocysts. Survival rates were compared by X2 analysis. In experiment I, there were no significant differences in mouse embryo survival or development between NCS, SH, and PVA groups (84.1, 79.2, and 83.3%, respectively). In experiment II, there were no significant differences in bovine embryo survival between NCS and SH groups (67.2 and 67.7%), but both had significantly higher survival than the PVA group (37.9%: P < 0.05). In experiment III, there was a significantly lower (P < 0.05) embryo survival rate in the low-molecular-weight SH-1 group (18.6%) than in medium (SH-2)- or high (SH-3)-molecular-weight groups (78.6 and 92.5%, respectively). Although doubling the concentration of SH-1 in experiment IV resulted in improved embryo survival (63.4%), survival rates were significantly higher (P < 0.05) in the medium-molecular-weight (SH-2; 82.3%) and high-molecular-weight (SH-3; 86.0%) groups despite reduced concentrations of these compounds in the freezing medium. Results suggest that SH can be used to replace biological sera in embryo freezing media.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001040 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001040 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:D019CD5051D47BB95787A7AA7ABAB883CD3C6665
   |texte=   The Use of Sodium Hyaluronate in Freezing Media for Bovine and Murine Embryos
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021